|4Mar 21, 8:46 PM ET

Pacala Mark L 4

4 · Oncology Institute, Inc. · Filed Mar 21, 2023

Insider Transaction Report

Form 4
Period: 2023-03-17
Transactions
  • Award

    Common stock

    2023-03-17+6,56288,399 total
Footnotes (1)
  • [F1]Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date.

Documents

2 files
  • 4
    wf-form4_167944596405529.xmlPrimary

    FORM 4

  • EX-24

    POWER OF ATTORNEY FOR MARK L. PACALA